semaglutide weight loss utah Injections Utah Poison Control Center sees

Mounjaro is for maximum weight loss or dual benefit in diabetes

Semaglutide is a current option for some patients when an approved product fits the clinical goal

Importantly, Lillys overall portfolio is balanced (including diabetes, oncology, and immunology drugs), which gives it financial muscle to support aggressive marketing of its new obesity drugs

Patient education regarding expected versus concerning symptoms plays a crucial role in medication adherence and overall treatment success

That difference matters because trial headlines can make the newer drug sound automatically better, while real decisions depend on approval status, safety, access, cost, and your medical history

Two teams of in-house researchers analyzed anonymized patient data, coming to the same conclusions